Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16554527 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
Condition: Coronary Heart Disease
Intervention: Drug: Pactimibe, CS-505

Indicates status has not been verified in more than two years